You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 8, August 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Somogyi Effect in Patient With Hypopituitarism

David L. Vesely, MD, PhD; Albert Castro, PhD; Gerald S. Levey, MD

Arch Intern Med. 1976;136(8):936-938.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Insulin-induced posthypoglycemic hyperglycemia is an important cause of poorly controlled diabetes.1 This phenomenon, which is known as the Somogyi effect, is characterized by the following: (1) insulin-induced hypoglycemia and a rebound insulinresistant hyperglycemia; (2) negative urine tests for sugar and ketones, followed within several hours by substantial glycosuria and variable ketonuria; (3) wide daily fluctuations in blood glucose levels that are generally unrelated to dietary intake; (4) periods of mild hypothermia; and (5) nocturnal sweating and nightmares in patients with late-onset hypoglycemic effects. Although this clinical phenomenon was described initially by Somogyi and Kirstein,2 confirmed by numerous investigators,3-6 and thoroughly defined by Bloom et al,7 the basic mechanism underlying the compensatory insulin-resistant, hyperglycemia remains unexplained. A general consensus appears to have formed ascribing an important role for anterior hypophyseal hormones, particularly growth hormone, in the pathogenesis of the rebound hyperglycemia.1.8-10 This present case report demonstrates . . . [Full Text PDF of this Article]


Author Affiliations

From the Division of Endrocrinology and Metabolism, Department of Medicine, University of Miami School of Medicine, Fla.


Footnotes

Received for publication Dec 17, 1975; accepted Dec 31.

Reprint requests to Division of Endocrinology and Metabolism, Department of Medicine, University of Miami School of Medicine, PO Box 520875, Biscayne Annex, Miami, FL 33152 (Dr Levey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.